Live Nasdaq Composite: Cautious Optimism Takes Hold as Chip Stocks Rebound and SpaceX IPO Nears

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Sep 4, 2016 at 10:40 AM EDT

5 Speculative Biotech Analyst Stocks Under $10 With Massive Upside

What most investors are looking for is a solid solution in what is a confusing market. So we have compiled…

Douglas A. McIntyre | Sep 4, 2016 at 10:29 AM EDT

Can Marijuana Help Alzheimer’s Patients?

This year marks a watershed in state legalization of marijuana, triggered by a change in social norms, the taxation yield…

Jon C. Ogg | Sep 2, 2016 at 11:35 AM EDT

How This Analyst Views Hillary Clinton’s Proposed Drug Price Hike Monitoring

One election year hot-button issue that is back on the table is the ongoing fight over drug prices. But the…

Chris Lange | Sep 2, 2016 at 7:40 AM EDT

8 Major FDA Decisions and Trial Results to Watch for in September

24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.

Chris Lange | Sep 1, 2016 at 11:40 AM EDT

Why Boston Scientific Shares Could Rise Almost 40% More as Turnaround Continues

If the independent research firm Argus is correct, then Boston Scientific shareholders could see an upside of roughly 40% from…

Chris Lange | Sep 1, 2016 at 10:05 AM EDT

Is Sunovion Overpaying for Cynapsus?

Shares of Cynapsus Therapeutics more than doubled on Thursday after it was announced that Sunovion Pharmaceuticals would be acquiring the…

Douglas A. McIntyre | Aug 31, 2016 at 8:40 AM EDT

Suffering From Another Debacle, Theranos CEO Elizabeth Holmes Is One of the Least Powerful People In The World

According to The Wall Street Journal, blood testing company Theranos and its CEO Elizabeth Holmes have suffered a new, major…

Lee Jackson | Aug 31, 2016 at 8:20 AM EDT

3 Biotech Stocks Could Be the Next Big Takeover Targets

In a new research report, Baird notes two biotech companies in its research coverage universe that may be considered speculative…

Chris Lange | Aug 30, 2016 at 12:20 PM EDT

Array BioPharma Continues Its Silent Rally With Mid-Stage Trial Win

Shares of Array BioPharma saw a handy gain in Tuesdays session following the announcement of mid-stage results from its cardiomyopathy…

Chris Lange | Aug 30, 2016 at 10:05 AM EDT

Why Rigel Pharma Is Making a Run

Shares of Rigel Pharmaceuticals skyrocketed early on Tuesday after the company reported incredibly positive results from its late-stage blood platelet…

Jon C. Ogg | Aug 29, 2016 at 1:10 PM EDT

An Outside View on St. Jude Device Cyberattack Woes

St. Jude Medical has issued a press release aimed at responding to points in the Muddy Waters report, and a…

Chris Lange | Aug 29, 2016 at 12:50 PM EDT

Why AstraZeneca Could Gain Another 15% Despite Market Headwinds

Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research…

Douglas A. McIntyre | Aug 29, 2016 at 6:37 AM EDT

US Food and Drug Administration Approves Zika Test

From PR Newswire: Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has…

Paul Ausick | Aug 27, 2016 at 10:05 AM EDT

FDA Recommends Zika Test for All Blood Donations

The FDA has issued a recommendation for universal testing of donated whole blood and blood components for the Zika virus…

Trey Thoelcke | Aug 26, 2016 at 8:20 AM EDT

Sanofi Just Can’t Catch a Break, Knocking at Major Support Again

At this point, bad news is coming in consistently to the point that any significant piece of good news could…

1 … 196 197 198 199 200 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

5 Speculative Biotech Analyst Stocks Under $10 With Massive Upside

Can Marijuana Help Alzheimer’s Patients?

How This Analyst Views Hillary Clinton’s Proposed Drug Price Hike Monitoring

8 Major FDA Decisions and Trial Results to Watch for in September

Why Boston Scientific Shares Could Rise Almost 40% More as Turnaround Continues

Is Sunovion Overpaying for Cynapsus?

Suffering From Another Debacle, Theranos CEO Elizabeth Holmes Is One of the Least Powerful People In The World

3 Biotech Stocks Could Be the Next Big Takeover Targets

Array BioPharma Continues Its Silent Rally With Mid-Stage Trial Win

Why Rigel Pharma Is Making a Run

An Outside View on St. Jude Device Cyberattack Woes

Why AstraZeneca Could Gain Another 15% Despite Market Headwinds

US Food and Drug Administration Approves Zika Test

FDA Recommends Zika Test for All Blood Donations

Sanofi Just Can’t Catch a Break, Knocking at Major Support Again

Live Nasdaq Composite: Cautious Optimism Takes Hold as Chip Stocks Rebound and SpaceX IPO Nears

Leveraged ETFs Do Work. This One Turned $10K into $3.64m in 16 Years

Nvidia Breaks Below $200, Approaches Bear Market Territory. How Much Further Can It Fall?

This AI Prodigy Has Returned 1,000% And Now Manages $20 Billion. Here’s His Most Recent Buys

Why a $1.4 Million 401(k) Makes That Side Hustle Far More Expensive Than You Think

What a $1.5 Million Dividend Portfolio Actually Pays a Retired Couple After Federal Tax, State Tax, and IRMAA

Leveraged ETFs Do Work. This One Turned $10K into $3.64m in 16 Years

Nvidia Breaks Below $200, Approaches Bear Market Territory. How Much Further Can It Fall?

Health and Healthcare Articles

All Health and Healthcare Articles

5 Speculative Biotech Analyst Stocks Under $10 With Massive Upside

Can Marijuana Help Alzheimer’s Patients?

How This Analyst Views Hillary Clinton’s Proposed Drug Price Hike Monitoring

8 Major FDA Decisions and Trial Results to Watch for in September

Why Boston Scientific Shares Could Rise Almost 40% More as Turnaround Continues

Is Sunovion Overpaying for Cynapsus?

Suffering From Another Debacle, Theranos CEO Elizabeth Holmes Is One of the Least Powerful People In The World

3 Biotech Stocks Could Be the Next Big Takeover Targets

Array BioPharma Continues Its Silent Rally With Mid-Stage Trial Win

Why Rigel Pharma Is Making a Run

An Outside View on St. Jude Device Cyberattack Woes

Why AstraZeneca Could Gain Another 15% Despite Market Headwinds

US Food and Drug Administration Approves Zika Test

FDA Recommends Zika Test for All Blood Donations

Sanofi Just Can’t Catch a Break, Knocking at Major Support Again

Live Nasdaq Composite: Cautious Optimism Takes Hold as Chip Stocks Rebound and SpaceX IPO Nears

Leveraged ETFs Do Work. This One Turned $10K into $3.64m in 16 Years

Nvidia Breaks Below $200, Approaches Bear Market Territory. How Much Further Can It Fall?

This AI Prodigy Has Returned 1,000% And Now Manages $20 Billion. Here’s His Most Recent Buys

Featured Reads

Why a $1.4 Million 401(k) Makes That Side Hustle Far More Expensive Than You Think

What a $1.5 Million Dividend Portfolio Actually Pays a Retired Couple After Federal Tax, State Tax, and IRMAA